Current Pharmaceutical Biotechnology

Papers
(The H4-Index of Current Pharmaceutical Biotechnology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Acknowledgement to Reviewers81
Potential Pathogens Associated with Colorectal Cancer47
Strategy of Virtual Screening based Discovery of HSP90 C-terminal Inhibitors and Network Pharmacological Analysis47
Spray Drying: A Promising Technique for Inhalable Vaccine Development45
Tryptophan Stability and Palatability in the Food Formulation: A Review43
Genotoxic Impurities in Critical Analysis of Product Development: Recent Advancements, Patents, and Current Challenges40
Exploring Therapeutic Frontiers: Unveiling the Potential of Natural Diterpenoid Derivatives in Addressing Neurological Disorders35
Foldable/Expandable Gastro-retentive Films Based on Starch and Chitosan as a Carrier For Prolonged Release of Resveratrol34
Protective Role of Glibenclamide and Magnesium Sulfate in Fructoseinduced Type 2 Diabetes Mellitus32
Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders31
An Exploration of Organoid Technology: Present Advancements, Applications, and Obstacles31
Nerolidol-potential Therapeutic Agent for Various Neurological Disorders via its Antioxidative Property29
Review on Natural Bioactive Products as Radioprotective Therapeutics: Present and Past Perspective28
Hydrogel Breakthroughs in Biomedicine: Recent Advances and Implications26
FDA-approved CAR T-cell Therapy: A Decade of Progress and Challenges26
Xiaoyao Pill Improves the Affective Dysregulation of Sleep-deprived Female Mice by Inhibiting Brain Injury and Regulating the Content of Monoamine Neurotransmitter25
Polygonati Rhizoma Alleviates Vascular Dementia through Regulating Microglial Polarization Transitions Mediated by NF-κB/NLRP3 Pathway25
A Review on Edible Vaccines and Biopharmaceutical Products from Plants24
Pharmacological Action and Research Progress of Taraxasterol24
WITHDRAWN: Current Synopsis on siRNA Therapeutics as a Novel Anti- Cancer and Antiviral Strategy: Progress and Challenges23
Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme23
Development of Daruharidra (Berberis aristata) Based Biogenic Cadmium Sulfide Nanoparticles: Their Implementation as Antibacterial and Novel Therapeutic Agents against Human Breast and Ovarian Cancer23
Novel Leflunomide Analog, UTLOH-4e, Ameliorates Gouty Arthritis Induced by Monosodium Urate Via NF-κB/NLRP3 Signaling Pathway23
0.086217880249023